About This Event
HOW TO FIND THE VENUE
DEEP TECH WEEK
Welcome to the Premier Biotech Event of Deep Tech Week.
Full speaker, panel, and showcase schedules to be announced.
*
EXPLORE THE CUTTING EDGE OF:
· AI & Gene Therapy
· Nanotechnology & Drug Delivery
· Diagnostics & Therapeutics
· Longevity & Regenerative Medicine
· Healthcare Innovation
· Venture Capital in a Rapidly Evolving Ecosystem
· State-of-the-Art Biomedical Sciences
*
CONFIRMED SPEAKERS
Professor of Genetics, Harvard Medical School
Founding Director, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard
Co-founder, Sirtris Pharmaceuticals (acquired by GSK for $720M)
Co-founder of MetroBiotech, EdenRoc Sciences, Tally Health, and Life Biosciences
Author of Lifespan: Why We Age and Why We Don't Have To
*
Biotechnologist, Futurist, and Founder of the Human Genome Project-Write
Chairman, Genome Project-write & Center of Excellence for Engineering Biology
Founder, Humane Genomics & Former Distinguished Researcher in the Bio/Nano Programmable Matter department at Autodesk
Expert in synthetic biology and biomanufacturing innovation
Co-author, The Genesis Machine: Our Quest to Rewrite Life in the Age of Synthetic Biology
*
Director, Strategic Innovation, Chiesi USA
Biochemist | Scientific Advisor | Mentor | Consultant
MIT's Innovator under 35 (2019)
*
CEO & Founder, Atomistic Insights
Computational Biophysicist | Chemist
Creating Computational Approaches for Next-Generation Dynamic Protein Modeling
*
Head of Healthcare Ventures, Lingotto Innovation ($6Bn AUM)
Venture Capitalist | Bioengineer | Medical Engineer
Previously: Medical researcher, scientist and operator with roles at OpenAI, Perkin Elmer, NASA, venture funds and early-stage startups; Applied research in medical robotics, cardiovascular engineering and artificial muscles @ Stanford
*
General Partner, Terran Applied
Deep Tech & Life Sciences Investor | Former Biologics Manufacturing @ Amgen
Previously: MBA @ Harvard, B.S. ChemE @ MIT
*
Investment Professional, In-Q-Tel (
Deep Tech, Biotech, AI & Software Investor | National Security
Previously: MBA, JD @ Harvard Business School & Harvard Law School
*
General Partner, Actual VC
Investing in Science-First Companies to Scale Impact | Forbes 30 Under 30 (Retail & E-commerce, 2021)
Previously: Co-Founder & CEO, ClearMask (Built and Scaled to $40MM ARR before Exit) | Biochemistry & Molecular Biology, Clinical Researcher, MHSc @ Johns Hopkins University
*
*
VP, Head of BD & Strategic Alliances, Arbor Biotechnologies; Partner, SummitBio Advisory
Drug Developer | Company Builder | Corporate Strategist | Deal Maker for Advanced Therapies
Previously: Novartis, Editas Medicines
*
Senior Director, Alliance Management, Nutcracker Therapeutics
Molecular Biologist | Drug Discovery & Design | Personalized Therapeutics
Making medicine more accessible and individualized via novel RNA therapeutic concepts
*
CEO & Founder, Precigenetics
Live, continuous single-cell biophotonics & multi-omics
Previously: UPenn Computer Science, Computational Bio
*
CEO & Founder, Ligandal
Inventor (88 patents) | Forbes 30 Under 30 (Healthcare, 2021)
Biomedical Engineer & Drug/Gene Delivery Nanoscientist
*
Additional Speakers TBA
*
EVENT SCHEDULE:
*
BRIEF NETWORKING
12:00 12:25 PM
*
OPENING REMARKS & A NOTE FROM OUR SPONSOR (ACTUAL.VC)
PRELUDES TO THE FUTURE OF MEDICINE (LIGANDAL)
12:25 - 12:30
*
FIRESIDE CHAT: BIOMANUFACTURING, BIOSECURITY, AND THE FUTURE OF BIODEFENSE
12:30 - 1 PM
Featuring: Andrew Hessel & Andre Watson (Ligandal)
*
LIGHTNING TALKS: FROM PREDICTION TO DX TO TX
*
ATOMISTIC INSIGHTS: PROTEIN DYNAMICS FOR BREAKTHROUGH MEDICINES
1 – 1:10 PM
Featuring: Katie Kuo, PhD (Atomistic Insights)
*
NON-INVASIVE, CONTINUOUS, SINGLE-CELL MULTI-OMIC DIAGNOSTICS OF THE FUTURE
1:10 – 1:20 PM
Featuring: Paramita Mishra (Precigenetics)
*
FROM PROMISE TO PATIENT: DELIVERING PERSONALIZED THERAPIES WITH MICROFLUIDIC MANUFACTURING SOLUTIONS
1:20 – 1:30 PM
Featuring: Nicole Fay (Nutcracker Therapeutics)
*
SPEED NETWORKING & MATCHMAKING
1:30 – 2:00 PM
*
PANEL: BRIDGING THE BIOTECH VALLEY OF DEATH: HOW VENTURE CAPITAL CAN DRIVE INNOVATION IN UNCERTAIN ECONOMIES
2:00 - 2:30 PM
Featuring: Ileana Pirozzi (Lingotto), Aaron Hsu (Actual VC), Curtis Wu (Terran Applied), James Lim (In-Q-Tel), Andre Watson (Ligandal)
Moderated by Luila Zaimi (The Longevity Adaptation Foundation, Tech M&A @ Deutsche Bank)
*
THE FUTURE OF PRECISION MEDICINE: HOW PHARMA CAN LEAD IN AN ERA OF CURATIVE THERAPIES
2:30 – 3:00 PM
Featuring: Ester Caffarel-Salvador (Chiesi), Kristine Yu (Arbor Bio)
Moderated by Nicole Fay (Nutcracker Tx)
*
FIRESIDE CHAT: NANOTECHNOLOGY, PRECISION GENE THERAPY, AND OUR FUTURE OF CURATIVE MEDICINE
3:00 - 3:30 PM
Featuring: Nicole Fay (Nutcracker Tx), Andre Watson (Ligandal)
*
FEATURED SESSION
FIRESIDE CHAT: THE FUTURE OF LONGEVITY
3:30 - 4:00 PM
Featuring: David Sinclair (Harvard Medical School) & Andre Watson (Ligandal)
Speakers
Ester Caffarel-Salvador
Director, Strategic Innovation, Chiesi USA
Ester Caffarel-Salvador is a biomedical engineer known for her work in innovative drug delivery systems and ingestible sensors. She has a background in academic research, including contributions at institutions like MIT, and has transitioned to industry roles focused on strategic innovation. In her current position, she leads initiatives at Chiesi USA to advance pharmaceutical technologies.
Curtis Wu
General Partner, Terran Applied
Curtis Wu is a General Partner at Terran Applied, bringing expertise in venture capital and business strategy with his MBA background. He has spoken at events like the Ligandal: Future of Biotech Summit, indicating his involvement in emerging technologies within the biotech sector. His role focuses on investing in innovative deep tech areas, leveraging his professional experience to support advancements in these fields.
David Sinclair
Professor of Genetics, Harvard Medical School
David Sinclair is a professor in the Department of Genetics at Harvard Medical School and a leading researcher in the biology of aging. He is known for his work on sirtuins and NAD+ metabolism, aiming to develop interventions that could extend human healthspan.
Katie Kuo
CEO & Founder, Atomistic Insights
Katie Kuo is the CEO and Founder of Atomistic Insights, a company specializing in AI-driven solutions for materials discovery and atomic-scale simulations. She has established the company to advance innovations in materials science, drawing on expertise in technology and entrepreneurship. Under her leadership, Atomistic Insights is making strides in applying AI to real-world scientific challenges.
James Lim
Investment Professional, In-Q-Tel
James Lim is an investment professional at In-Q-Tel, a company that focuses on investing in advanced technologies for the U.S. intelligence community. With a JD and MBA, he brings expertise in legal and business aspects to his role in identifying and supporting innovative tech ventures. He has participated in events such as the Ligandal: Future of Biotech Summit, indicating his involvement in biotech-related discussions.
Andrew Hessel
Biotechnologist, Futurist, and Founder of the Human Genome Project-Write, Genome Project-write
Andrew Hessel is a biotechnologist and futurist known for his work in synthetic biology and genomics. He is the founder of the Genome Project-write, an initiative aimed at synthesizing the human genome, and has contributed to advancements in biotechnology through various research and speaking engagements. In his current role, he continues to explore the future applications of genetic engineering and biotechnology.
Ileana Pirozzi
Head of Healthcare Ventures, Lingotto Innovation
Ileana Pirozzi is the Head of Healthcare Ventures at Lingotto Innovation, where she leads investments in healthcare technologies and innovations. With a background in venture capital, she has been involved in identifying and supporting startups that advance medical solutions. Her role focuses on strategic investments in the health sector to drive impactful developments.
